Michael Kyriakides

Director/Miembro de la Junta en

Purespring Therapeutics Ltd.

Consumer Services

Finance

Health Technology

Perfil

Michael Kyriakides is a Board Member at Purespring Therapeutics Ltd. since 2022.
Formerly, Mr. Kyriakides was an Investment Partner at Syncona Partners LLP.
Mr. Kyriakides completed undergraduate, graduate, and doctorate degrees at Imperial College London in 2010, 2011, and 2014 respectively.

Cargos activos de Michael Kyriakides

Empresas	Cargo	Inicio
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Director/Miembro de la Junta	01/04/2022

Todos los cargos activos de Michael Kyriakides

Antiguos cargos conocidos de Michael Kyriakides.

Empresas	Cargo	Fin
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Inversor de Capital Privado	-

Ver el detalle de la experiencia de Michael Kyriakides.

Formación de Michael Kyriakides.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Kyriakides.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Imperial College London Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Finance
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Health Technology